---
title: "Galecto Inc. Held Special Shareholder Meeting"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/275462958.md"
description: "Galecto Inc. held a special shareholder meeting on February 9, 2026, where stockholders approved the company's redomestication to the Cayman Islands and the adoption of new memorandum and articles of association. Additionally, the 2026 Equity Incentive Plan and the 2026 Employee Stock Purchase Plan were also approved."
datetime: "2026-02-10T13:03:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275462958.md)
  - [en](https://longbridge.com/en/news/275462958.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275462958.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/275462958.md) | [繁體中文](https://longbridge.com/zh-HK/news/275462958.md)


# Galecto Inc. Held Special Shareholder Meeting

Galecto Inc. held a special meeting of stockholders on February 9, 2026. At the meeting, stockholders approved the redomestication of the company to the Cayman Islands and the adoption of new memorandum and articles of association. The Galecto, Inc. 2026 Equity Incentive Plan and the 2026 Employee Stock Purchase Plan were also approved. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galecto Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-043741), on February 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### 相关股票

- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [iShares US Pharma (IHE.US)](https://longbridge.com/zh-CN/quote/IHE.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-CN/quote/XLV.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [VG Health (VHT.US)](https://longbridge.com/zh-CN/quote/VHT.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-CN/quote/IXJ.US.md)
- [Galecto (GLTO.US)](https://longbridge.com/zh-CN/quote/GLTO.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [Direxion S&P Biotech Bear 3X (LABD.US)](https://longbridge.com/zh-CN/quote/LABD.US.md)
- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-CN/quote/ARKG.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [Damora Therapeutics (DMRA.US)](https://longbridge.com/zh-CN/quote/DMRA.US.md)

## 相关资讯与研究

- [Galecto Rebrands as Damora Therapeutics with New Ticker](https://longbridge.com/zh-CN/news/278556054.md)
- [BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering | BTAI Stock News](https://longbridge.com/zh-CN/news/278602207.md)
- [Argenx Unveils New VYVGART and Neurology Pipeline Data Ahead of 2026 AAN Meeting](https://longbridge.com/zh-CN/news/278091205.md)
- [Prelude Therapeutics reports $99.5 mln net loss for 2025](https://longbridge.com/zh-CN/news/278542482.md)
- [BUZZ-Scienture rises after deals to expand reach of opioid overdose spray](https://longbridge.com/zh-CN/news/278723928.md)